Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature
Emily Hinchcliff(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Samuel C. Mok(The University of Texas MD Anderson Cancer Center), Sarah Kelting(University of New Mexico), Jason Roszik(The University of Texas MD Anderson Cancer Center), Mark H. Stoler(University of Virginia), Weiyi Peng(University of Houston), Qian Zhang(Jiangsu Province Hospital), Patrick Hwu(Moffitt Cancer Center), Tsz-Lun Yeung(The University of Texas MD Anderson Cancer Center), Cherie Paquette(Brown University), Melinda S. Yates(University of North Carolina at Chapel Hill)
Cited by 34
Related Papers
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
|Archives of Pathology & Laboratory Medicine|2012|999